Cowen Inc’s HI-TECH PHARMACAL INC HITK Stock Holding History

Cowen Inc’s Portfolio HITK Stock Details HITK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2013 Q4	–	Sell	-49,511	Closed	-$2.14M	–	296
2013 Q3	$2.14M	Buy	+49,511	New	+$1.9M	0.32%	53

Other funds holding HITK

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

LIM

Longfellow Investment Management Boston, Massachusetts $489M AUM 9.58% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Cowen Inc's HITK Position: Q4 2013 in Review

Cowen Inc sold out of HI-TECH PHARMACAL INC (HITK) in Q4 2013, closing a stake of 49,511 shares — an estimated $2.14M sold.

Cowen Inc first reported a position in HITK in Q3 2013 and held it in 1 quarter. The position peaked at $2.14M in Q3 2013. 101 funds tracked by Wall St. Rank hold HITK as of Q4 2013.

Cowen Inc reported no remaining HI-TECH PHARMACAL INC position as of Q4 2013 after selling out during the quarter.
Cowen Inc sold 49,511 HI-TECH PHARMACAL INC shares in Q4 2013, an estimated $2.14M.
Cowen Inc first reported a position in HI-TECH PHARMACAL INC in Q3 2013 and held it in 1 quarter.
Cowen Inc's HI-TECH PHARMACAL INC position peaked at $2.14M in Q3 2013.
101 funds tracked by Wall St. Rank held HI-TECH PHARMACAL INC as of Q4 2013.

Based on Cowen Inc's 13F filing for Q4 2013, filed 13 Feb 2014.